Califf Deftly Defuses Sunscreen, DSHEA Probes In Confirmation Hearing

This article was originally published in The Tan Sheet

18 Nov 2015
News

Eileen Francis eileen.francis@informa.com

Executive Summary

FDA commissioner nominee Robert Califf suggests adequate evidence is key to moving sunscreen TEAs through FDA’s evaluation process during his Senate confirmation hearing. He just as smoothly handled HELP Committee members’ questions about DSEHA and FDA rulemaking.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United States

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Consumer BioPharmaceutical Medical Device

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS108027

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS108027

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Califf Deftly Defuses Sunscreen, DSHEA Probes In Confirmation Hearing

News

Executive Summary

Related Content

Sharfstein Suggests Requiring Supplements Registration, Testing Standards

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert